Eos INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
EOS Inc. filed Amendment No. 5 to its Form 10-K to clarify risks associated with operating in China and Hong Kong, including regulatory and legal uncertainties.
OTC.Pink
EOS Inc. files an amendment to its 2023 annual report to clarify subsidiary information, auditor details, enforceability of judgments, and risk factors related to operations in Hong Kong, China, and Taiwan.
OTC.Pink
EOS Inc. has filed an amendment to its 2023 annual report to clarify subsidiary roles, management responsibilities, auditor details, and risk factors related to Hong Kong operations.
OTC.Pink
EOS Inc. has filed an amendment to its annual report to include risks related to doing business in Hong Kong, disclose information on its Principal Financial Officer, and update its principal address.
OTC.Pink
EOS Inc. has filed an amendment to its annual report on Form 10-K to include cybersecurity disclosures, revised internal control reporting, and additional financial details.
OTC.Pink
EOS Inc. reports a net loss of $631,936 for 2023, an improvement from the $1,912,159 loss in 2022, as the company transitions to a resource integration service provider.